Antidepressant pharmacotherapy of depression associated with multiple sclerosis
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
In a double-blind clinical trial involving 28 patients with multiple sclerosis and major depressive disorder, 14 patients were randomly assigned to a 5-week trial of desipramine and individual psychotherapy and 14 to placebo plus psychotherapy. Clinical judgments indicated that patients treated with desipramine improved significantly more than the placebo group. This was confirmed by scores on the Hamilton Rating Scale for Depression but not by Beck Depression Inventory scores. Side effects limited desipramine dosage in half of the treated patients. The authors conclude that desipramine has a modest beneficial effect in serious depression associated with multiple sclerosis but that side effects may be more of a limiting factor than in patients without medical or neurologic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Research works printed but not linked: 27
- 10.1136/jnnp.s1-7.25.1 · DOI
- 10.1001/archneur.1984.04050210065016 · DOI · Paper page
- 10.1192/bjp.115.524.749 · DOI · Paper page
- 10.1136/jnnp.43.10.861 · DOI · Paper page
- 10.1002/ana.410130517 · DOI · Paper page
- 10.1016/0163-8343(87)90052-1 · DOI · Paper page
- 10.1001/archneur.1987.00520160018007 · DOI · Paper page
- 10.1176/ajp.143.1.94 · DOI · Paper page
- 10.1176/ajp.141.1.112 · DOI
- 10.1176/ajp.98.2.243 · DOI
- 10.1097/00005053-194309000-00004 · DOI
- 10.1136/jnnp.14.4.326 · DOI
- 10.1093/brain/109.4.585 · DOI · Paper page
- 10.1056/NEJM198506063122303 · DOI · Paper page
- 10.1001/archneurpsyc.1939.02270220011001 · DOI
- 10.1192/bjp.126.4.346 · DOI · Paper page
- 10.7326/0003-4819-67-4-695 · DOI · Paper page
- Stewart JA, 1965, Dis Nerv Syst, 26, 479
- Rifkin A, 1985, J Clin Psychiatry, 46, 4
- 10.1001/archpsyc.1985.01790350034007 · DOI · Paper page
- 10.1111/j.1600-0404.1980.tb03028.x · DOI · Paper page
- 10.1016/S0140-6736(84)90356-8 · DOI · Paper page
- 10.1001/archneur.1987.00520180020009 · doi:10.1001/archneur.1987.00520180020009
- 10.1176/ajp.140.11.1498 · DOI
- 10.1001/archneur.1987.00520140053017 · DOI
- 10.1001/archpsyc.1978.01770310043002 · DOI · Paper page
- 10.1176/ajp.136.1.52 · DOI · Paper page
Cited by
Depression in multiple sclerosis: a review
Siegert, R. J. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054635 · Cited by 718
Cuijpers, P., Noma, H., Karyotaki, E., Vinkers, C. H., Cipriani, A., & Furukawa, T. A. (2020) · World Psychiatry · doi:10.1002/wps.20701 · Cited by 540
The link between multiple sclerosis and depression
Feinstein, A., Magalhaes, S., Richard, J.-F., Audet, B., & Moore, C. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.139 · Cited by 523
Depression and Chronic Medical Illness
Sachdeva, S., Cohen, D., Singh, A. K., Kaul, P., & Schwartz, T. L. (2009) · Medical Psychiatry · doi:10.3109/9781420084887.012 · Cited by 496
Multiple sclerosis and depression
Feinstein, A. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511417835 · Cited by 337
Mohr, D. C., Boudewyn, A. C., Goodkin, D. E., Bostrom, A., & Epstein, L. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.6.942 · Cited by 334
The Goldman Consensus statement on depression in multiple sclerosis
Goldman Consensus Group (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1162oa · Cited by 329
Cuijpers, P., van Straten, A., Warmerdam, L., & Andersson, G. (2009) · Depression and Anxiety · doi:10.1002/da.20519 · Cited by 281
Depression in patients with cancer
Mermelstein, H. T., & Lesko, L. (1992) · Psycho-Oncology · doi:10.1002/pon.2960010404 · Cited by 266
Depression in multiple sclerosis
Patten, S. B., Marrie, R. A., & Carta, M. G. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1322555 · Cited by 262
“The first randomized controlled trial of depression in MS evaluated desipramine, a tricyclic antidepressant (Schiffer & Wineman, 1990), and subsequent studies examined sertraline (Mohr, Boudewyn, Goodkin, Bostrom, & Epstein, 2001) and paroxetine (Ehde et al., 2008), two serotonin-specific…”
BackgroundThe Neuropsychiatry of Multiple Sclerosis
Feinstein, A. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900302 · Cited by 252
Pollak, Y., & Yirmiya, R. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003152 · Cited by 215
Cytokines, “depression due to a general medical condition”, and antidepressant drugs
Yirmiya, R., Weidenfeld, J., Pollak, Y., Morag, M., Morag, A., Avitsur, R., Barak, O., Reichenberg, A., Cohen, E., Shavit, Y., et al. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_16 · Cited by 208
Ramasubbu, R., Taylor, V. H., Samaan, Z., Sockalingham, S., Li, M., Patten, S., Rodin, G., Schaffer, A., Beaulieu, S., & McIntyre, R. S. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400110 · Cited by 206
Fiest, K. M., Walker, J. R., Bernstein, C. N., Graff, L. A., Zarychanski, R., Abou-Setta, A. M., Patten, S. B., Sareen, J., Bolton, J. M., Marriott, J. J., et al. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.10.004 · Cited by 198
Multiple sclerosis: Empirical literature for the clinical health psychologist
Mohr, D. C., & Cox, D. (2001) · Journal of Clinical Psychology · doi:10.1002/jclp.1042 · Cited by 176
Psychiatric Issues in Multiple Sclerosis
Chwastiak, L. A., & Ehde, D. M. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2007.07.003 · Cited by 166
Treatment of depression in multiple sclerosis: Review and meta-analysis.
Mohr, D. C., & Goodkin, D. E. (1999) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.6.1.1 · Cited by 155
Fischer, A., Schröder, J., Vettorazzi, E., Wolf, O. T., Pöttgen, J., Lau, S., Heesen, C., Moritz, S., & Gold, S. M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00049-2 · Cited by 143
Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis
Ehde, D. M., Kraft, G. H., Chwastiak, L., Sullivan, M. D., Gibbons, L. E., Bombardier, C. H., & Wadhwani, R. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.08.002 · Cited by 107
Pharmacologic treatment of depression in multiple sclerosis
Koch, M. W., Glazenborg, A., Uyttenboogaart, M., Mostert, J., & De Keyser, J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007295.pub2 · Cited by 105
Depression and multiple sclerosis: Review of a lethal combination
Wallin, M. T., Wilken, J. A., Turner, A. P., Williams, R. M., & Kane, R. (2006) · The Journal of Rehabilitation Research and Development · doi:10.1682/jrrd.2004.09.0117 · Cited by 101
Price, A., Rayner, L., Okon-Rocha, E., Evans, A., Valsraj, K., Higginson, I. J., & Hotopf, M. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.230862 · Cited by 90
Cuijpers, P., Van Straten, A., Hollon, S. D., & Andersson, G. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01513.x · Cited by 74
Depression Associated with Medical Illness: Treatment Considerations
Fava, G. A., & Sonino, N. (1996) · CNS Drugs · doi:10.2165/00023210-199605030-00004 · Cited by 53
Askey-Jones, S., David, A. S., Silber, E., Shaw, P., & Chalder, T. (2013) · Behaviour Research and Therapy · doi:10.1016/j.brat.2013.04.001 · Cited by 32
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1990-11-01
- Volume
- 147
- Issue
- 11
- Pages
- 1493-1497
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W135319519
- Cited by
- 200
- References
- 2
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.